Sarcopenic obesity is not associated with sexual dysfunction in older adults: a cross-sectional study.

IF 2.7 4区医学 Q3 ENDOCRINOLOGY & METABOLISM Aging Male Pub Date : 2023-12-01 Epub Date: 2023-10-31 DOI:10.1080/13685538.2023.2252502

Filiz Demirdağ, Burcu Kıvrak Güçer, Esma Nur Kolbaşı

{"title":"Sarcopenic obesity is not associated with sexual dysfunction in older adults: a cross-sectional study.","authors":"Filiz Demirdağ, Burcu Kıvrak Güçer, Esma Nur Kolbaşı","doi":"10.1080/13685538.2023.2252502","DOIUrl":null,"url":null,"abstract":"Background: This study aimed to investigate the frequency of sexual dysfunction (SD) and the association between SD and body composition abnormalities, such as sarcopenia, obesity, and sarcopenic obesity.Methods: Older adults (≥65 years) were included. Sarcopenic obesity was diagnosed by using newly defined ESPEN-EASO diagram. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People criteria. Obesity was defined using the fat percentile cut-offs suggested by ESPEN-EASO. SD was determined by Arizona Sexual Experience Scale (ASEX).Results: Two-hundred and sixty-seven volunteers (64.4% female, mean age 73.63 ± 6.22 years) participated in this study. One-hundred seventy-eight individuals (66.7%) had SD. It was present in 83.1% and 36.8% of the females and males, respectively (p < 0.0001). There was no association between SD and sarcopenia alone (OR: 1.359, 95% CI: 0.650-2.838, p = 0.415) or obesity alone (OR: 0.986, 95% CI: 0.543-1.791, p = 0.963). Sarcopenic obesity was significantly associated with SD (OR: 9.116, 95% CI: 1.173-70.851, p = 0.035). However, this significance was lost after the model was adjusted for gender, marital status, and comorbidities (OR: 4.676, 95% CI: 0.578-37.801, p = 0.148).Conclusions: SD was present in 66.7% of the older adults and was not associated with sarcopenia, obesity, or sarcopenic obesity. Further longitudinal studies are needed on this topic.","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Male","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13685538.2023.2252502","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This study aimed to investigate the frequency of sexual dysfunction (SD) and the association between SD and body composition abnormalities, such as sarcopenia, obesity, and sarcopenic obesity.

Methods: Older adults (≥65 years) were included. Sarcopenic obesity was diagnosed by using newly defined ESPEN-EASO diagram. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People criteria. Obesity was defined using the fat percentile cut-offs suggested by ESPEN-EASO. SD was determined by Arizona Sexual Experience Scale (ASEX).

Results: Two-hundred and sixty-seven volunteers (64.4% female, mean age 73.63 ± 6.22 years) participated in this study. One-hundred seventy-eight individuals (66.7%) had SD. It was present in 83.1% and 36.8% of the females and males, respectively (p < 0.0001). There was no association between SD and sarcopenia alone (OR: 1.359, 95% CI: 0.650-2.838, p = 0.415) or obesity alone (OR: 0.986, 95% CI: 0.543-1.791, p = 0.963). Sarcopenic obesity was significantly associated with SD (OR: 9.116, 95% CI: 1.173-70.851, p = 0.035). However, this significance was lost after the model was adjusted for gender, marital status, and comorbidities (OR: 4.676, 95% CI: 0.578-37.801, p = 0.148).

Conclusions: SD was present in 66.7% of the older adults and was not associated with sarcopenia, obesity, or sarcopenic obesity. Further longitudinal studies are needed on this topic.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

一项横断面研究显示，老年人的肌肉型肥胖与性功能障碍无关。

背景：本研究旨在调查性功能障碍（SD）的频率以及SD与身体成分异常（如少肌症、肥胖和少肌性肥胖）之间的关系。方法：老年人（≥65岁）年）。应用新定义的ESPEN-EASO图诊断肌肉型肥胖。Sarcopenia是根据欧洲老年人Sarcopeniia工作组的标准诊断的。肥胖是使用ESPEN-EASO建议的脂肪百分位截断值来定义的。SD采用亚利桑那性经验量表（ASEX）测定。结果：167名志愿者（64.4%为女性，平均年龄73.63岁） ± 6.22 年）参与了这项研究。178人（66.7%）患有SD，女性和男性分别为83.1%和36.8%（p p = 0.415）或单独肥胖（or:0.986，95%CI:0.543-1791，p = 肌萎缩性肥胖与SD显著相关（OR:9.116，95%CI:1.173-70.851，p = 0.035）。然而，在对模型进行性别、婚姻状况和合并症调整后，这种显著性消失了（OR:4.676，95%CI:0.578-37.801，p = 0.148）。结论：66.7%的老年人存在SD，与少肌症、肥胖或少肌性肥胖无关。需要对这一主题进行进一步的纵向研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Aging Male 医学-泌尿学与肾脏学

CiteScore

6.40

自引率

3.80%

发文量

审稿时长

>12 weeks

期刊介绍： The Aging Male , the official journal of the International Society for the Study of the Aging Male, is a multidisciplinary publication covering all aspects of male health throughout the aging process. The Journal is a well-recognized and respected resource for anyone interested in keeping up to date with developments in this field. It is published quarterly in one volume per year. The Journal publishes original peer-reviewed research papers as well as review papers and other appropriate educational material that provide researchers with an integrated perspective on this new, emerging specialty. Areas of interest include, but are not limited to: Diagnosis and treatment of late-onset hypogonadism Metabolic syndrome and related conditions Treatment of erectile dysfunction and related disorders Prostate cancer and benign prostate hyperplasia.